• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Moderna's Loss in Q1 Was Less Than Expected

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 05, 2024 at 11:52: PM
via
  • Moderna's earnings per share exceeded analyst predictions but were still well down from 2023's Q1.
  • Revenue for Q1 showcased significant outperformance compared to analysts' forecasts.
  • Moderna reaffirmed its full-year 2024 financial outlook.

article source
 

<



Similar threads

cafead
Moderna takes axe to &#039;24 sales guidance, sending shares lower
Replies
0
Views
45
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Moderna co-founder Robert Langer to step down from vaccine maker&#039;s board
Replies
0
Views
13
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA approves Moderna&#039;s RSV vaccine with lower-than-expected efficacy in its label
Replies
0
Views
15
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA delays decision on Moderna&#039;s RSV shot until the end of May
Replies
0
Views
115
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
CureVac, chasing Moderna&#039;s mRNA flu vaccine, runs into the same B strain problems
Replies
0
Views
108
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote